Choice architecture-based prescribing tool for TB preventive therapy: a pilot study in South Africa

G Caturegli, J Materi, A Lombardo… - Public Health …, 2020 - ingentaconnect.com
Background: All people with HIV who screen negative for active tuberculosis (TB) should
receive isoniazid preventive therapy (IPT). IPT implementation remains substantially below …

Choice architecture-based prescribing tool for TB preventive therapy: a pilot study in South Africa.

G Caturegli, J Materi, A Lombardo, M Milovanovic… - 2020 - cabidigitallibrary.org
Background: All people with HIV who screen negative for active tuberculosis (TB) should
receive isoniazid preventive therapy (IPT). IPT implementation remains substantially below …

[HTML][HTML] Choice architecture-based prescribing tool for TB preventive therapy: a pilot study in South Africa

G Caturegli, J Materi, A Lombardo… - Public Health …, 2020 - ncbi.nlm.nih.gov
Background: All people with HIV who screen negative for active tuberculosis (TB) should
receive isoniazid preventive therapy (IPT). IPT implementation remains substantially below …

Choice architecture-based prescribing tool for TB preventive therapy: a pilot study in South Africa

G Caturegli, J Materi, A Lombardo… - Public health …, 2020 - pubmed.ncbi.nlm.nih.gov
Background All people with HIV who screen negative for active tuberculosis (TB) should
receive isoniazid preventive therapy (IPT). IPT implementation remains substantially below …

Choice architecture-based prescribing tool for TB preventive therapy: a pilot study in South Africa.

G Caturegli, J Materi, A Lombardo… - Public Health …, 2020 - europepmc.org
Background All people with HIV who screen negative for active tuberculosis (TB) should
receive isoniazid preventive therapy (IPT). IPT implementation remains substantially below …

Choice architecture-based prescribing tool for TB preventive therapy: a pilot study in South Africa.

G Caturegli, J Materi, A Lombardo… - Public Health …, 2020 - europepmc.org
Background All people with HIV who screen negative for active tuberculosis (TB) should
receive isoniazid preventive therapy (IPT). IPT implementation remains substantially below …